{"title":"1型糖尿病患者血糖浓度的控制","authors":"Surekha Kamath","doi":"10.1109/PACC.2011.5979042","DOIUrl":null,"url":null,"abstract":"As the \"artificial pancreas\" becomes closer to reality, automated insulin delivery based on real-time glucose measurements becomes feasible for people with diabetes. This paper employs a new approach to regulate the blood glucose level of type I diabetic patient under an intensive insulin treatment. The closed-loop control scheme incorporates the design of robust H¿¿ controller to maintain the normoglycemic average of 80 mg/dl. Due to cost and complexity involved in testing the control algorithms to real patients, studies are done using a Type I diabetic patient model. Controller performance is assessed in terms of its ability to reject the effect of meal disturbance and to overcome the variability in the glucose-insulin dynamics from patient to patient. Computer simulations are used to evaluate the effectiveness of the proposed technique and to show its superiority in controlling hyperglycemia over other existing algorithms.","PeriodicalId":403612,"journal":{"name":"2011 International Conference on Process Automation, Control and Computing","volume":"20 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2011-07-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"4","resultStr":"{\"title\":\"Control of Blood Glucose Concentration in Type I Diabetic Patients\",\"authors\":\"Surekha Kamath\",\"doi\":\"10.1109/PACC.2011.5979042\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"As the \\\"artificial pancreas\\\" becomes closer to reality, automated insulin delivery based on real-time glucose measurements becomes feasible for people with diabetes. This paper employs a new approach to regulate the blood glucose level of type I diabetic patient under an intensive insulin treatment. The closed-loop control scheme incorporates the design of robust H¿¿ controller to maintain the normoglycemic average of 80 mg/dl. Due to cost and complexity involved in testing the control algorithms to real patients, studies are done using a Type I diabetic patient model. Controller performance is assessed in terms of its ability to reject the effect of meal disturbance and to overcome the variability in the glucose-insulin dynamics from patient to patient. Computer simulations are used to evaluate the effectiveness of the proposed technique and to show its superiority in controlling hyperglycemia over other existing algorithms.\",\"PeriodicalId\":403612,\"journal\":{\"name\":\"2011 International Conference on Process Automation, Control and Computing\",\"volume\":\"20 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2011-07-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"4\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"2011 International Conference on Process Automation, Control and Computing\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1109/PACC.2011.5979042\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"2011 International Conference on Process Automation, Control and Computing","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1109/PACC.2011.5979042","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Control of Blood Glucose Concentration in Type I Diabetic Patients
As the "artificial pancreas" becomes closer to reality, automated insulin delivery based on real-time glucose measurements becomes feasible for people with diabetes. This paper employs a new approach to regulate the blood glucose level of type I diabetic patient under an intensive insulin treatment. The closed-loop control scheme incorporates the design of robust H¿¿ controller to maintain the normoglycemic average of 80 mg/dl. Due to cost and complexity involved in testing the control algorithms to real patients, studies are done using a Type I diabetic patient model. Controller performance is assessed in terms of its ability to reject the effect of meal disturbance and to overcome the variability in the glucose-insulin dynamics from patient to patient. Computer simulations are used to evaluate the effectiveness of the proposed technique and to show its superiority in controlling hyperglycemia over other existing algorithms.